Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Conduit Pharmaceuticals Inc. (CDT)
Company Research
Source: GlobeNewswire
SAN DIEGO and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), today announced it will be participating in the H.C. Wainwright 26th Annual Global Investment Conference, being held September 9-11, 2024. Dr. David Tapolczay, Founder and CEO of Conduit, will give a virtual presentation available on-demand starting on September 9th at 7:00 am ET/12:00 pm BST. Dr. Tapolczay will also be available for in-person, one-on-one investor meetings throughout the conference being held at Lotte New York Palace Hotel, 455 Madison Avenue, New York City. To view Dr. Tapolczay’s presentation, please use the following link to register via H.C. Wainwright’s website (www.hcwevents.com/annualconference). A webcast of the presentation will also be available on the Company Events section of the Company’s website at (www.conduitpharma.com). About Conduit Pharmaceuticals Conduit is a multi-asset, clinical stage, disease-agnostic life science
Show less
Read more
Impact Snapshot
Event Time:
CDT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDT alerts
High impacting Conduit Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
CDT
News
- Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model [Yahoo! Finance]Yahoo! Finance
- Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus ModelGlobeNewswire
- Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note [Yahoo! Finance]Yahoo! Finance
- Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured NoteGlobeNewswire
- Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug DevelopmentGlobeNewswire
CDT
Sec Filings
- 2/14/25 - Form 424B3
- 2/13/25 - Form EFFECT
- 2/11/25 - Form 8-K
- CDT's page on the SEC website